Trial Profile
Denosumab Fracture Intervention Randomized Placebo Controlled Trial in Japanese Patients With Osteoporosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Jun 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 06 Jun 2016 New trial record